News | May 12, 2020
Merck doubles down on Skyhawk’s tech to drug RNA, promising $600M per autoimmune, metabolic target
Read More
News | March 31, 2020
Latest Penn biotech spinout taking on cancer raises $1.6M from investors
Read More
Press Release | March 26, 2020
First Patient Dosed in EVICTION Trial Evaluating ImCheck’s Lead Anti-Cancer Drug, ICT01: A Novel Gamma Delta T Cell-Activating Immunotherapy
Read More
News | March 23, 2020
First-of-its-kind Engineered Macrophage Cell Therapy Platform Shows Ability to Reduce Tumor Burden and Activate Anti-Tumor Immunity, Improving Overall Survival in Pre-Clinical Cancer Models
Read More
